Joan edukira
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Hizkuntza
Eremu guztiak
Izenburua
Egilea
Gaia
Sailkapena
ISBN/ISSN
Etiketa
Bilatu
Aurreratua
THE ADDITION OF CETUXIMAB TO O...
Erreferentzia bihurtu
SMS
Bidali
Imprimir
Erregistroa esportatu
Nora RefWorks
Nora EndNoteWeb
Nora EndNote
Permanent link
THE ADDITION OF CETUXIMAB TO OXALIPLATIN-FLUOROPYRIMIDINE CHEMOTHERAPY IN FIRST-LINE ADVANCED COLORECTAL CANCER IN THE MRC COIN TRIAL: IDENTIFICATION OF POTENTIALLY RESPONSIVE SUBSETS OF PATIENTS
Xehetasun bibliografikoak
Egile Nagusiak:
Maughan, T
,
Adams, R
,
Smith, C
,
Seymour, M
,
Wilson, R
,
Meade, A
,
Fisher, D
,
Madi, A
,
Cheadle, J
,
Kaplan, R
Formatua:
Conference item
Argitaratua:
2010
Aleari buruzko argibideak
Deskribapena
Antzeko izenburuak
MARC erregistroa
Antzeko izenburuak
Toxicity associated with combination oxaliplatin plus fluoropyrimidine with or without cetuximab in the MRC COIN trial experience.
nork: Adams, R, et al.
Argitaratua: (2009)
THE IMPACT OF MILD RENAL IMPAIRMENT ON THE TOXICITY OF OXALIPLATIN AND FLUOROPYRIMIDINE REGIMENS: EXPERIENCE IN THE MRC COIN TRIAL
nork: Madi, A, et al.
Argitaratua: (2010)
Addition of cetuximab to oxaliplatin-based combination chemotherapy (CT) in patients with KRAS wild-type advanced colorectal cancer (ACRC): a randomised superiority trial (MRC COIN)
nork: Maughan, T, et al.
Argitaratua: (2009)
INTERMITTENT VS. CONTINUOUS OXALIPLATIN-FLUOROPYRIMIDINE CHEMOTHERAPY IN THE MRC COIN TRIAL IN ADVANCED COLORECTAL CANCER: UPDATED EFFICACY RESULTS, QUALITY OF LIFE AND POTENTIAL PREDICTIVE FACTORS
nork: Adams, R, et al.
Argitaratua: (2010)
Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: the MRC COIN trial.
nork: Madi, A, et al.
Argitaratua: (2012)